Pfizer Inc.

PFE

US7170811035

Pharmaceuticals

Market Closed - Nyse Other stock markets 08:00:02 14/02/26 am AEDT			After hours 12:00:00 pm
27.58 ^USD	+0.40%		27.77	+0.69%

14/02	Actinium Pharmaceuticals, Inc. Announces Principal Financial Officer Changes, Effective as of February 27, 2026	CI
13/02	Celcuity Inc. Appoints Charles Romp to Its Board of Directors	CI

Trump pressures 17 pharma CEOs to cut US drug prices

Published on 08/01/2025 at 07:54 am AEST

Reuters

Latest news about Pfizer Inc.

14/02	Actinium Pharmaceuticals, Inc. Announces Principal Financial Officer Changes, Effective as of February 27, 2026	CI
13/02	Celcuity Inc. Appoints Charles Romp to Its Board of Directors	CI
13/02	Verrica Pharmaceuticals Inc. Appoints Chris Chapman as Chief Commercial Officer	CI
12/02	Analyst recommendations: Pfizer, Applovin, Biogen, Hilton, Snap…
12/02	Daiwa Securities Downgrades Pfizer to Neutral From Outperform, Price Target is $27	MT
12/02	Pharma companies left out of Trump's drug-pricing deals look for way in	RE
12/02	Pharma companies left out of Trump's drug-pricing deals look for way in	RE
11/02	Pfizer to collect $29 million from SEC case against Steven A. Cohen hedge fund	RE
10/02	Entera Bio appoints former Pfizer executive Geno J. Germano as chairman of the board ahead of key milestones	RE
10/02	Pfizer Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
10/02	Entera Bio Ltd. Announces Board Changes	CI
10/02	Pfizer Dec-quarter net profit 1.42 billion rupees	RE
07/02	TrumpRx has limited reach at launch beyond weight-loss drugs, experts say	RE
07/02	Pfizer Inc. Announced That FDA Has Accepted and Granted Priority Review for the Company's Supplemental Biologics License Application	CI
06/02	Pfizer Receives US FDA Priority Review for Expanded Hemophilia Treatment Use	MT

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (47.4%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (26.2%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (24.5%); - other (1.9%). The United States accounts for 60.8% of net sales.

Employees

81,000

Sector

Pharmaceuticals

Calendar

05/05 - Q1 2026 Earnings Release (Projected)

More about the company